206 related articles for article (PubMed ID: 23909468)
21. Rituximab for treatment of autoimmune hemolytic anemia.
Kuzmanovic M; Jurisic V
Indian Pediatr; 2012 Aug; 49(8):672-4. PubMed ID: 22962244
[TBL] [Abstract][Full Text] [Related]
22. Long-term response to rituximab in patients with relapsing thrombotic thrombocytopenic purpura.
Stein GY; Blickstein D; Orlin J; Sarig G; Inbal A
Isr Med Assoc J; 2011 Jul; 13(7):398-401. PubMed ID: 21838180
[TBL] [Abstract][Full Text] [Related]
23. Warm autoimmune hemolytic anemia: advances in pathophysiology and treatment.
Michel M
Presse Med; 2014 Apr; 43(4 Pt 2):e97-e104. PubMed ID: 24680421
[TBL] [Abstract][Full Text] [Related]
24. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
D'Arena G; Califano C; Annunziata M; Tartarone A; Capalbo S; Villani O; Amendola G; Pietrantuono G; Ferrara F; Pinto A; Musto P; D'Arco AM; Cascavilla N
Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766
[TBL] [Abstract][Full Text] [Related]
25. Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies.
Barcellini W; Zaja F; Zaninoni A; Imperiali FG; Battista ML; Di Bona E; Fattizzo B; Consonni D; Cortelezzi A; Fanin R; Zanella A
Blood; 2012 Apr; 119(16):3691-7. PubMed ID: 22267606
[TBL] [Abstract][Full Text] [Related]
26. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
27. [Rituximab instead of splenectomy in 4 children with chronic or refractory autoimmune haemolytic anaemia].
van Daalen ST; van Dijken PJ; Tamminga RY; Brons PP
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2350-4. PubMed ID: 16261716
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients.
Gobert D; Bussel JB; Cunningham-Rundles C; Galicier L; Dechartres A; Berezne A; Bonnotte B; DeRevel T; Auzary C; Jaussaud R; Larroche C; LeQuellec A; Ruivard M; Seve P; Smail A; Viallard JF; Godeau B; Hermine O; Michel M
Br J Haematol; 2011 Nov; 155(4):498-508. PubMed ID: 21981575
[TBL] [Abstract][Full Text] [Related]
29. [Lower dose of rituximab in the treatment of elderly autoimmune hemolytic anemia].
Zhang X; Sun J
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):236-8. PubMed ID: 24666491
[TBL] [Abstract][Full Text] [Related]
30. Emergence of long-lived autoreactive plasma cells in the spleen of primary warm auto-immune hemolytic anemia patients treated with rituximab.
Mahévas M; Michel M; Vingert B; Moroch J; Boutboul D; Audia S; Cagnard N; Ripa J; Menard C; Tarte K; Mégret J; Le Gallou S; Patin P; Thai L; Galicier L; Bonnotte B; Godeau B; Noizat-Pirenne F; Weill JC; Reynaud CA
J Autoimmun; 2015 Aug; 62():22-30. PubMed ID: 26112660
[TBL] [Abstract][Full Text] [Related]
31. Livedo reticularis associated with autoimmune hemolytic anemia: prolonged remission induced by peripheral blood stem cell transplantation relapse after 10 years and restoration of hemoglobin levels by rituximab.
Ferreira E; Feitosa A; Hamerschlak N; Scheinberg MA
Rev Bras Reumatol; 2012; 52(1):122-4. PubMed ID: 22286652
[TBL] [Abstract][Full Text] [Related]
32. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
Cianchini G; Lupi F; Masini C; Corona R; Puddu P; De Pità O
J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765
[TBL] [Abstract][Full Text] [Related]
33. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
34. [Delayed response to rituximab of cold agglutinin haemolytic disease].
Calvo-Villas JM; Cuesta Tovar J; Carreter de Granda E; Sicilia Guillén F
An Med Interna; 2006 May; 23(5):224-8. PubMed ID: 16817700
[TBL] [Abstract][Full Text] [Related]
35. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
[TBL] [Abstract][Full Text] [Related]
36. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
[TBL] [Abstract][Full Text] [Related]
37. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
38. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
39. Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.
Svahn J; Fioredda F; Calvillo M; Molinari AC; Micalizzi C; Banov L; Schmidt M; Caprino D; Marinelli D; Gallisai D; Dufour C
Br J Haematol; 2009 Apr; 145(1):96-100. PubMed ID: 19208098
[TBL] [Abstract][Full Text] [Related]
40. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
Swords R; Nolan A; Fay M; Quinn J; O'Donnell R; Murphy PT
Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
